REVIEW: γ‐Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State

Aims: Drugs currently used for the treatment of Alzheimer's disease (AD) partially stabilize patients’ symptoms without modifying disease progression. Brain accumulation of oligomeric species of β‐amyloid (Aβ) peptides, the principal components of senile plaques, is believed to play a crucial r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:CNS Neurosci Ther
Autors principals: Panza, Francesco, Frisardi, Vincenza, Imbimbo, Bruno P., Capurso, Cristiano, Logroscino, Giancarlo, Sancarlo, Daniele, Seripa, Davide, Vendemiale, Gianluigi, Pilotto, Alberto, Solfrizzi, Vincenzo
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2010
Matèries:
Alzheimer's Disease
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493789/
https://ncbi.nlm.nih.gov/pubmed/20560993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2010.00164.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars